Form 4 Filing for Oric Pharmaceuticals, Inc.

This filing details transactions made by Dominic Piscitelli, Chief Financial Officer of Oric Pharmaceuticals, Inc. On September 24, 2026, Piscitelli acquired 600 shares of Common Stock at a price of $4.36 per share. Subsequently, he disposed of 100 shares at $13.50 per share and another 500 shares at $13.505 per share. These sales were executed under a Rule 10b5-1 trading plan. Additionally, a stock option for 600 shares with an exercise price of $4.36 was exercised on the same date, resulting in 91,900 shares owned following the transaction. The filing also notes the disposal of 100 shares at $13.50 and 500 shares at $13.505, with post-transaction holdings of 70,328 and 69,828 shares respectively.